Fluorescence-Guided Surgery for Sarcoma

This trial tests a new method to help surgeons remove sarcomas, a type of cancer, more effectively. It compares regular surgery to Fluorescence-Guided Surgery, where a special dye, Indocyanine Green, illuminates the tumor, aiding surgeons in its complete removal. This approach could reduce the risk of leaving cancer cells behind. Individuals diagnosed with intermediate to high-grade sarcoma and planning surgery may be suitable for this trial. As a Phase 2 trial, the research focuses on measuring the treatment's effectiveness in an initial, smaller group of participants.

Research has shown that fluorescence-guided surgery (FGS) with indocyanine green is generally safe and well-tolerated. Indocyanine green, a dye, helps surgeons identify cancerous tissue during surgery. Surgeons have successfully used this technique in other cancer surgeries to remove more cancer while preserving healthy tissue.

Studies have found that FGS can reduce the likelihood of leaving cancerous cells behind after surgery, which is crucial for lowering the risk of cancer recurrence. The method's safety is supported by its use in numerous surgeries, with no significant safety concerns reported.

Fluorescence-Guided Surgery (FGS) is unique because it uses a special dye called indocyanine green (ICG) to make cancer cells light up during surgery. This innovative approach allows surgeons to see and remove cancerous tissue more precisely than with standard surgical techniques alone. Researchers are excited because FGS has the potential to reduce the risk of leaving behind cancer cells, which can lead to better outcomes and fewer repeat surgeries for patients with sarcoma.

This trial will compare standard surgical resection with fluorescence-guided surgery (FGS) for sarcoma. Research has shown that FGS, using a dye called indocyanine green, helps surgeons distinguish between cancerous and healthy tissue. This method reduces the chances of leaving cancer cells behind by lowering positive margin rates. One study found that FGS makes it easier for doctors to remove all the cancer, often eliminating the need for a second surgery. In various types of cancer, FGS has greatly improved the accuracy of tumor removal. This suggests that FGS could effectively treat sarcoma by enhancing surgical success.⁶⁷⁸⁹¹⁰